loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 213004 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 REDHILL (1)

filter

01 CAPSULE, DELAYED RELEASE;ORAL (1)

filter

01 RX (1)

filter

01 TALICIA (1)

filter

01 Yes (1)

URL Supplier Web Content
CAPSULE, DELAYED R...
250MG;EQ 10MG BASE...
2019-11-01
213004
TALICIA
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 213004

Looking for FDA Orange Book APPLICATION 213004 1

19

RedHill Biopharma, based in Israel, is a pharmaceutical company.

One of their notable products is AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN, with a corresponding application number 213004.

Regulatory Information RX

With a dosage strength 250MG;EQ 10MG BASE;12.5MG

Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

Reference Listed Drug Yes

Approved since 2019-11-01

Post Enquiry
POST ENQUIRY